Wang, Yifan
Zhang, Zhening
Li, Yufei
Cheng, Yongjing
Wang, Min
Liu, Yudong
Li, Hao
Peng, Zhi
He, Jing
Funding for this research was provided by:
Research Ward Excellence Clinical Research Program (BRWEP2024W034080206)
National Key Research and Development Program of China (2022YFE0131700)
National Natural Science Foundation of China (82071813)
Beijing Nova Program (20220484206)
Article History
Received: 25 January 2026
Accepted: 1 June 2026
First Online: 9 June 2026
Declarations
:
: The authors declare no potential conflicts of interest in this work.
: Human study was conducted following the Declaration of Helsinki and received approval from the ethics committee of Peking University Cancer Hospital (2022KT125). Animal studies received ethical approval from the Institutional Animal Care and Use Committee (IACUC) of Peking University Health Science Center (2021PHE026).
: Patients signed written informed consent to collect biospecimens and anonymously use their clinical and molecular data for research purposes.